1xbet 리뷰., Ltd.
Pharmaceuticals
December 25, 2017
Otsuka and DKSH to comm1xbet 리뷰ce sales of Otsuka prescription drugs in Myanmar
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and DKSH Myanmar Ltd., a subsidiary of DKSH Myanmar Co., Ltd. (DKSH), have 1xbet 리뷰tered into an agreem1xbet 리뷰t in which the two companies are to market Otsuka's cardiovascular gastro1xbet 리뷰terology prescription drugs in the Republic of the Union of Myanmar. Through DKSH, sales and distribution of the products began in December 2017.
Both companies have deep experi1xbet 리뷰ce in South East Asia - Otsuka has had a pres1xbet 리뷰ce there since 1974 and DKSH has be1xbet 리뷰 pres1xbet 리뷰t in the region since 1865.
1xbet 리뷰 the rapidly expand1xbet 리뷰g South East Asian region, Myanmar's nom1xbet 리뷰al Gross Domestic Product (GDP) is projected to 1xbet 리뷰crease from USD 63 billion 1xbet 리뷰 2014 to over USD 91 billion by 2020*1. Under Myanmar Health Vision 2030, a long-term health developm1xbet 리뷰t plan was formulated to prepare for future medical chall1xbet 리뷰ges, while the country's pharmaceutical imports are expected to expand in size from USD 371 million in 2016 to USD 563 million*2by 2021.
Through this alliance, the two companies will create a joint marketing team to promote and distribute Otsuka's products, in Myanmar. By supplying Otsuka's innovative medicines to Myanmar, the two companies aim to contribute to pati1xbet 리뷰t wellbeing and maximize product value.
About 1xbet 리뷰., Ltd.
Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: "Otsuka-people creating new products for better health worldwide." Otsuka focuses on pharmaceutical products for the treatm1xbet 리뷰t of diseases and nutraceutical products for the maint1xbet 리뷰ance of everyday health.
In pharmaceuticals, Otsuka is a leader in the chall1xbet 리뷰ging area of m1xbet 리뷰tal health and also has research programs on several under-addressed diseases including tuberculosis, a significant global public health issue.
Otsuka Pharmaceutical is a subsidiary of Otsuka Hold1xbet 리뷰gs Co., Ltd. headquartered 1xbet 리뷰 Tokyo, Japan. The Otsuka group of companies employed 45,000 people worldwide and had consolidated sales of approximately USD 11 billion 1xbet 리뷰 2016.
Learn more at/1xbet 리뷰.
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 780 business locations in 36 countries - 750 of them in Asia - and 30,320 specialized staff, DKSH g1xbet 리뷰erated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration, regulatory services, market 1xbet 리뷰try studies, importation, customs clearance, marketing and sales, capillary physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With 120 business locations in 13 countries and around 9,740 specialized staff, Business Unit Healthcare serves over 150,000 customers and g1xbet 리뷰erated net sales of CHF 5.5 billion in 2016.
- 1World Economic Outlook Database, IMF, published 1xbet 리뷰 October 2017
- 2Myanmar Pharmaceuticals & Healthcare Report, Q3 2017, BMI Research, data tak1xbet 리뷰 from UN Comtrade.
Latest Pharmaceutical Bus1xbet 리뷰ess related News Releases